Asset
Oxytocin
Tonix Pharmaceuticals Holding Corp. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05679908 | phase2 | completed | 2022-12-06 | 2023-10-08 | Tonix Pharmaceuticals, Inc. | A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine |
FDA applications (0)
This company has no applications containing this asset.